OTC Consumer Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Individuals affected by common illnesses such as cold, cough, and headache typically turn to widely available non-prescription drugs. These over-the-counter (OTC) remedies are favored for their convenience and quick relief, often within two days. The frequent use of such products has significantly boosted the demand for oral healthcare items, as consumers predominantly choose OTC healthcare options from renowned brands. Companies' efforts in promoting their brand names play a crucial role in their growth within the OTC consumer healthcare market.

Risks Associated with OTC Medication Abuse

While OTC medications offer easy access to treatment, their misuse can lead to addiction and dependency, posing serious health risks. Additionally, the COVID-19 pandemic created widespread panic, which further spiked the sales of immunity boosters globally as people sought to enhance their health defenses.

Strategic Alliances and Partnerships Driving Market Expansion

Strategic alliances and partnerships are instrumental in broadening market access and fostering business growth in the OTC consumer healthcare sector. Well-established players are enhancing their foothold in emerging economies through such collaborations. For example, in 2017, Bayer AG partnered with AliHealth (Alibaba Health) to promote self-care products in China. This was the first instance of a consumer health company signing a memorandum of cooperation with AliHealth on uni-marketing.

Growing Popularity of OTC Healthcare Products

OTC consumer healthcare products, including analgesics, oral healthcare, wound care, and medicated skin care, are gaining traction among consumers. This popularity is significantly contributing to pharmaceutical sales. Increased product awareness and marketing efforts by key players in emerging markets are expected to drive steady sales growth in the coming years.

Shift Toward Natural Medicinal Products

Consumer preferences are gradually shifting toward natural medicinal products and supplements, including OTC healthcare items. The perception that natural ingredients are more effective and offer greater health benefits is driving the growth of natural products in the OTC healthcare category.

Dominance of Analgesics in the Market

Pain management is a common medical concern, making analgesics the most frequently used OTC drugs for self-treatment. The availability of various painkillers with different potencies has led to a steady rise in analgesics sales. This segment is expected to continue dominating the OTC consumer healthcare market due to its increasing adoption.

Challenges Posed by Inconsistent Regulatory Regimes

The OTC consumer healthcare market faces challenges due to inconsistent regulatory frameworks across different countries and regions. While some emerging economies have lenient regulations allowing easy access to certain drugs, other regions impose stricter controls. In Europe, regulatory aspects related to sales channels and pharmacist presence vary significantly between countries, leading to increased costs and limited consumer access.

Regional and Competitive Analysis of the OTC Consumer Healthcare Market

The OTC consumer healthcare market is poised for expansion, driven by the growth of local players in developing economies and strategic acquisitions by prominent companies. For instance, Ipsen SA acquired a portfolio of five consumer products from Sanofi S.A. in 2017 to expand its OTC offerings.

North America currently holds a dominant share of the global OTC consumer healthcare market, followed by Europe. In North America, the United States leads the market, while Germany and the United Kingdom together account for a significant share in Europe. East Asia, South Asia, and Oceania are expected to register substantial growth due to increasing health awareness and product availability.

Impact of COVID-19 on the OTC Consumer Healthcare Market

The COVID-19 pandemic has had a notable impact on the OTC consumer healthcare market. The global recovery rate of approximately 58% among COVID-19 patients has led businesses to adopt new sales channels. The pandemic has also increased the sales of OTC drugs due to heightened health concerns. During the pandemic, online sales channels gained prominence as people avoided physical stores. However, as the pandemic subsides, physical sales are anticipated to regain momentum.

Key Market Players

Sun Pharmaceutical Industries Limited
Glenmark Pharmaceuticals Ltd.
Johnson & Johnson Private Ltd, Pfizer, Inc.
American Health Corporation
Abbott Laboratories Inc.
GlaxoSmithKline plc
Sanofi S.A.
Piramal Enterprises Ltd.
Boehringer Ingelheim GmbH
Bayer AG
Teva Pharmaceutical Industries Ltd.
Ipsen SA, BASF SE
Koninklijke DSM N.V.
Reckitt Benckiser LLC.
Lonza Group Ltd.

Key Market Segmentation

Product

OTC Pharmaceuticals

Eye Care
Oral Health Care
Medicated Skin Care
Wound Care
Digestive Remedies
Sleeping Aids
Emergency Contraceptives
Intimate Care
Hair Care
Cough, Cold & Allergy Remedies
Analgesics
Dermatological
- Dietary Supplements
Nutrition
Vitamins
Minerals
Proteins
Others

End User

Male
Female
Kids

Sales Channel

Wholesalers & Distributors
Pharmacy or Drug Stores
Specialty Stores
Online Retailers
Hypermarkets/Supermarkets
Other Sales Channels

Form

Tablet
Powder
Liquid
Others

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

1. Executive Summary

1.1. Global OTC Consumer Healthcare Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global OTC Consumer Healthcare Market Outlook, 2019 - 2031

3.1. Global OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. OTC Pharmaceuticals
    - 3.1.1.1.1. Oral Healthcare
    - 3.1.1.1.2. Medicated Skincare
    - 3.1.1.1.3. Digestive Remedies
    - 3.1.1.1.4. Emergency Contraceptives
    - 3.1.1.1.5. Analgesics
    - 3.1.1.1.6. Others
  - 3.1.1.2. Dietary Supplements
    - 3.1.1.2.1. Vitamins
    - 3.1.1.2.2. Minerals
    - 3.1.1.2.3. Nutrition
    - 3.1.1.2.4. Proteins
    - 3.1.1.2.5. Others
3.2. Global OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Tablet
  - 3.2.1.2. Powder
  - 3.2.1.3. Liquid
  - 3.2.1.4. Others
3.3. Global OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hypermarkets/Supermarkets
  - 3.3.1.2. Wholesalers & Distributors
  - 3.3.1.3. Specialty Stores
  - 3.3.1.4. Pharmacy & Drug Stores
  - 3.3.1.5. Online Retailers
  - 3.3.1.6. Others
3.4. Global OTC Consumer Healthcare Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America OTC Consumer Healthcare Market Outlook, 2019 - 2031

4.1. North America OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. OTC Pharmaceuticals
    - 4.1.1.1.1. Oral Healthcare
    - 4.1.1.1.2. Medicated Skincare
    - 4.1.1.1.3. Digestive Remedies
    - 4.1.1.1.4. Emergency Contraceptives
    - 4.1.1.1.5. Analgesics
    - 4.1.1.1.6. Others
  - 4.1.1.2. Dietary Supplements
    - 4.1.1.2.1. Vitamins
    - 4.1.1.2.2. Minerals
    - 4.1.1.2.3. Nutrition
    - 4.1.1.2.4. Proteins
    - 4.1.1.2.5. Others
4.2. North America OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Tablet
  - 4.2.1.2. Powder
  - 4.2.1.3. Liquid
  - 4.2.1.4. Others
4.3. North America OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hypermarkets/Supermarkets
  - 4.3.1.2. Wholesalers & Distributors
  - 4.3.1.3. Specialty Stores
  - 4.3.1.4. Pharmacy & Drug Stores
  - 4.3.1.5. Online Retailers
  - 4.3.1.6. Others
4.4. North America OTC Consumer Healthcare Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.2. U.S. OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 4.4.1.3. U.S. OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 4.4.1.4. Canada OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 4.4.1.5. Canada OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 4.4.1.6. Canada OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe OTC Consumer Healthcare Market Outlook, 2019 - 2031

5.1. Europe OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. OTC Pharmaceuticals
    - 5.1.1.1.1. Oral Healthcare
    - 5.1.1.1.2. Medicated Skincare
    - 5.1.1.1.3. Digestive Remedies
    - 5.1.1.1.4. Emergency Contraceptives
    - 5.1.1.1.5. Analgesics
    - 5.1.1.1.6. Others
  - 5.1.1.2. Dietary Supplements
    - 5.1.1.2.1. Vitamins
    - 5.1.1.2.2. Minerals
    - 5.1.1.2.3. Nutrition
    - 5.1.1.2.4. Proteins
    - 5.1.1.2.5. Others
5.2. Europe OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Tablet
  - 5.2.1.2. Powder
  - 5.2.1.3. Liquid
  - 5.2.1.4. Others
5.3. Europe OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hypermarkets/Supermarkets
  - 5.3.1.2. Wholesalers & Distributors
  - 5.3.1.3. Specialty Stores
  - 5.3.1.4. Pharmacy & Drug Stores
  - 5.3.1.5. Online Retailers
  - 5.3.1.6. Others
5.4. Europe OTC Consumer Healthcare Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.2. Germany OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.3. Germany OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.4. U.K. OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.5. U.K. OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.6. U.K. OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.7. France OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.8. France OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.9. France OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.10. Italy OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.11. Italy OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.12. Italy OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.13. Turkey OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.14. Turkey OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.15. Turkey OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.16. Russia OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.17. Russia OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.18. Russia OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 5.4.1.19. Rest of Europe OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 5.4.1.20. Rest of Europe OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 5.4.1.21. Rest of Europe OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific OTC Consumer Healthcare Market Outlook, 2019 - 2031

6.1. Asia Pacific OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. OTC Pharmaceuticals
    - 6.1.1.1.1. Oral Healthcare
    - 6.1.1.1.2. Medicated Skincare
    - 6.1.1.1.3. Digestive Remedies
    - 6.1.1.1.4. Emergency Contraceptives
    - 6.1.1.1.5. Analgesics
    - 6.1.1.1.6. Others
  - 6.1.1.2. Dietary Supplements
    - 6.1.1.2.1. Vitamins
    - 6.1.1.2.2. Minerals
    - 6.1.1.2.3. Nutrition
    - 6.1.1.2.4. Proteins
    - 6.1.1.2.5. Others
6.2. Asia Pacific OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Tablet
  - 6.2.1.2. Powder
  - 6.2.1.3. Liquid
  - 6.2.1.4. Others
6.3. Asia Pacific OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hypermarkets/Supermarkets
  - 6.3.1.2. Wholesalers & Distributors
  - 6.3.1.3. Specialty Stores
  - 6.3.1.4. Pharmacy & Drug Stores
  - 6.3.1.5. Online Retailers
  - 6.3.1.6. Others
6.4. Asia Pacific OTC Consumer Healthcare Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.2. China OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.3. China OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.4. Japan OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.5. Japan OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.6. Japan OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.7. South Korea OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.8. South Korea OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.9. South Korea OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.10. India OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.11. India OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.12. India OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.13. Southeast Asia OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.14. Southeast Asia OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.15. Southeast Asia OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 6.4.1.16. Rest of Asia Pacific OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 6.4.1.17. Rest of Asia Pacific OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 6.4.1.18. Rest of Asia Pacific OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America OTC Consumer Healthcare Market Outlook, 2019 - 2031

7.1. Latin America OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. OTC Pharmaceuticals
    - 7.1.1.1.1. Oral Healthcare
    - 7.1.1.1.2. Medicated Skincare
    - 7.1.1.1.3. Digestive Remedies
    - 7.1.1.1.4. Emergency Contraceptives
    - 7.1.1.1.5. Analgesics
    - 7.1.1.1.6. Others
  - 7.1.1.2. Dietary Supplements
    - 7.1.1.2.1. Vitamins
    - 7.1.1.2.2. Minerals
    - 7.1.1.2.3. Nutrition
    - 7.1.1.2.4. Proteins
    - 7.1.1.2.5. Others
7.2. Latin America OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Tablet
  - 7.2.1.2. Powder
  - 7.2.1.3. Liquid
  - 7.2.1.4. Others
7.3. Latin America OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hypermarkets/Supermarkets
  - 7.3.1.2. Wholesalers & Distributors
  - 7.3.1.3. Specialty Stores
  - 7.3.1.4. Pharmacy & Drug Stores
  - 7.3.1.5. Online Retailers
  - 7.3.1.6. Others
7.4. Latin America OTC Consumer Healthcare Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.2. Brazil OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 7.4.1.3. Brazil OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.4. Mexico OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.5. Mexico OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 7.4.1.6. Mexico OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.7. Argentina OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.8. Argentina OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 7.4.1.9. Argentina OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 7.4.1.10. Rest of Latin America OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 7.4.1.11. Rest of Latin America OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 7.4.1.12. Rest of Latin America OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa OTC Consumer Healthcare Market Outlook, 2019 - 2031

8.1. Middle East & Africa OTC Consumer Healthcare Market Outlook, By Product, Value (US$ Bn), 2019 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. OTC Pharmaceuticals
    - 8.1.1.1.1. Oral Healthcare
    - 8.1.1.1.2. Medicated Skincare
    - 8.1.1.1.3. Digestive Remedies
    - 8.1.1.1.4. Emergency Contraceptives
    - 8.1.1.1.5. Analgesics
    - 8.1.1.1.6. Others
  - 8.1.1.2. Dietary Supplements
    - 8.1.1.2.1. Vitamins
    - 8.1.1.2.2. Minerals
    - 8.1.1.2.3. Nutrition
    - 8.1.1.2.4. Proteins
    - 8.1.1.2.5. Others
8.2. Middle East & Africa OTC Consumer Healthcare Market Outlook, By Form, Value (US$ Bn), 2019 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Tablet
  - 8.2.1.2. Powder
  - 8.2.1.3. Liquid
  - 8.2.1.4. Others
8.3. Middle East & Africa OTC Consumer Healthcare Market Outlook, By Sales Channel, Value (US$ Bn), 2019 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hypermarkets/Supermarkets
  - 8.3.1.2. Wholesalers & Distributors
  - 8.3.1.3. Specialty Stores
  - 8.3.1.4. Pharmacy & Drug Stores
  - 8.3.1.5. Online Retailers
  - 8.3.1.6. Others
8.4. Middle East & Africa OTC Consumer Healthcare Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.2. GCC OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 8.4.1.3. GCC OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.4. South Africa OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.5. South Africa OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 8.4.1.6. South Africa OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.7. Egypt OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.8. Egypt OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 8.4.1.9. Egypt OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.10. Nigeria OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.11. Nigeria OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 8.4.1.12. Nigeria OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
  - 8.4.1.13. Rest of Middle East & Africa OTC Consumer Healthcare Market By Product, Value (US$ Bn), 2019 - 2031
  - 8.4.1.14. Rest of Middle East & Africa OTC Consumer Healthcare Market By Form, Value (US$ Bn), 2019 - 2031
  - 8.4.1.15. Rest of Middle East & Africa OTC Consumer Healthcare Market By Sales Channel, Value (US$ Bn), 2019 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2022
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. Glenmark Pharmaceuticals Ltd.
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Product Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. Pfizer, Inc.
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Product Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. Abbott
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Product Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. GSK
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Product Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Bayer AG
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Product Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. Piramal Enterprises Ltd.
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Product Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development
- 9.3.7. Johnson and Johnson Pvt. Ltd.
  - 9.3.7.1. Company Overview
  - 9.3.7.2. Product Portfolio
  - 9.3.7.3. Financial Overview
  - 9.3.7.4. Business Strategies and Development
- 9.3.8. Sun Pharmaceutical Industries Ltd.
  - 9.3.8.1. Company Overview
  - 9.3.8.2. Product Portfolio
  - 9.3.8.3. Financial Overview
  - 9.3.8.4. Business Strategies and Development
- 9.3.9. Animal Health Corporation
  - 9.3.9.1. Company Overview
  - 9.3.9.2. Product Portfolio
  - 9.3.9.3. Financial Overview
  - 9.3.9.4. Business Strategies and Development
- 9.3.10. Boehringer Ingelheim GmbH
  - 9.3.10.1. Company Overview
  - 9.3.10.2. Product Portfolio
  - 9.3.10.3. Financial Overview
  - 9.3.10.4. Business Strategies and Development
- 9.3.11. BASF SE
  - 9.3.11.1. Company Overview
  - 9.3.11.2. Product Portfolio
  - 9.3.11.3. Financial Overview
  - 9.3.11.4. Business Strategies and Development
- 9.3.12. Koninklijke Philips N.V.
  - 9.3.12.1. Company Overview
  - 9.3.12.2. Product Portfolio
  - 9.3.12.3. Financial Overview
  - 9.3.12.4. Business Strategies and Development
- 9.3.13. Lonza Group Ltd.
  - 9.3.13.1. Company Overview
  - 9.3.13.2. Product Portfolio
  - 9.3.13.3. Financial Overview
  - 9.3.13.4. Business Strategies and Development
- 9.3.14. Teva Pharmaceutical Industries Ltd
  - 9.3.14.1. Company Overview
  - 9.3.14.2. Product Portfolio
  - 9.3.14.3. Financial Overview
  - 9.3.14.4. Business Strategies and Development
- 9.3.15. Reckitt Benckiser LLC
  - 9.3.15.1. Company Overview
  - 9.3.15.2. Product Portfolio
  - 9.3.15.3. Financial Overview
  - 9.3.15.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations